Hartwig, UF; Meyer, RG; Herr, W
Towards more Specificity and Effectivity in the Antileukemia Immune ResponseBritten CM, Kreiter S, Diken M, Rammensee H-G (Hrsg). Cancer Immunotherapy meets Oncology. Heidelberg, Dordrecht, London, New York: Springer 2014
Scholz, Christian W.; Pinto, Antonello; Linkesch, Werner et al.
(90)Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical TrialJOURNAL OF CLINICAL ONCOLOGY. Bd. 31. H. 3. 2013 S. 308-313
Freichels, Helene; Wagner, Manfred; Okwieka, Patricia et al.
(Oligo)mannose functionalized hydroxyethyl starch nanocapsules: en route to drug delivery systems with targeting propertiesJOURNAL OF MATERIALS CHEMISTRY B. Bd. 1. H. 34. 2013 S. 4338-4348
Eberhardt, Wilfried Ernst Erich; Gauler, Thomas Christoph; LePechoux, Cecile et al.
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-A multicenter phase-II trial (CISTAXOL)LUNG CANCER. Bd. 82. H. 1. 2013 S. 83-89
Gillessen, Silke; Gnad-Vogt, Ulrike S.; Gallerani, Elisa et al.
A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumoursEUROPEAN JOURNAL OF CANCER. Bd. 49. H. 1. 2013 S. 35-44
Witzens-Harig, Mathias; Memmer, Marie Luise; Dreyling, Martin et al.
A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma - the STORM trialBMC CANCER. Bd. 13. 2013
Schuette, Wolfgang H. W.; Groeschel, Andreas; Sebastian, Martin et al.
A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung CancerCLINICAL LUNG CANCER. Bd. 14. H. 3. 2013 S. 215-223
Reck, Martin; Krzakowski, Maciej; Chmielowska, Ewa et al.
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naive metastatic/unresectable non-small cell lung cancerLUNG CANCER. Bd. 82. H. 3. 2013 S. 441-448
Hoecherl, Anita; Landfester, Katharina; Mailaender, Volker
Absolute Quantitation of Sub-Micrometer Particles in Cells by Flow CytometryMACROMOLECULAR BIOSCIENCE. Bd. 13. H. 11. 2013 S. 1568-1575
Diken, M; Kreiter, S; Selmi, A et al.
Antitumor vaccination with synthetic mRNA: Strategies for in vitro and in vivo preclinical studiesMethods Mol Biol. Bd. 969. 2013 S. 235-46